EN
HI
Marksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
31.21 L
Market Cap
10819.09 CR
LTQ@LTP
10@238.68
ATP
244.82
Var Margin
22.09 %
Circuit Range
196.96-295.42
Delivery %
21.91 %
Value
76.40 CR
ASM/GSM
No
Market Lot
1
Summary
Marksans Pharma share price is ₹238.68 as of 1 Jun, 2026. The stock Marksans Pharma intraday movement has stayed between ₹235.25 and ₹256.00, while on a 52-week basis,Marksans Pharma price 52 week high is ₹270.70 & its 52 week low is ₹155.00.
In terms of trading activity, Marksans Pharma has recorded a volume of 3120848 shares, The Marksans Pharma has a market cap of ₹453288438 CR. The stock’s Average Traded Price (ATP) stands at ₹244.82, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹238.68.
Marksans Pharma operates within a circuit range of ₹196.96 – ₹295.42, with a Value of ₹76.40 CR. The Delivery Percentage for the day is 21.91%. Additionally, Marksans Pharma currently falls under the No framework, and trades with a market lot size of 1.
Marksans Pharma Fundamentals
View MoreP/E Ratio
26.69
P/B Ratio
3.69
Div. Yield
0.37
Sector P/E
69.53
Sector P/B
2.99
Sec. Div. Yield
0.55
Marksans Pharma Resistance and Support
Pivot 249.27
Resistance
First Resistance
257.91
Second Resistance
269.64
Third Resistance
278.28
Support
First Support
237.54
Second Support
228.9
Third Support
217.17
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma acquired 100% of Netherlands-based QliniQ B.V. for €7.5 million. This acquisition strengthens its presence in regulated European markets and provides direct access to the Dutch healthcare market.
Jun 01 2026 08:57:48
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Marksans Pharma uploaded the audio recording of its Q4 FY26 investor/analyst conference call. The recording, covering the financial results discussed on May 27, 2026, is now available on the company's website for investor review.
May 27 2026 18:52:29
Read More
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Alivus Life Sciences Ltd.
1048.00
-7.50 (0.71%)
Park Medi World Ltd.
274.05
-14.49 (5.02%)
Metropolis Healthcare Ltd.
540.85
-14.50 (2.61%)
Sanofi Consumer Healthcare India Ltd.
4586.70
-1.80 (0.04%)
Viyash Scientific Ltd.
250.40
-11.54 (4.41%)
Concord Biotech Ltd.
1061.30
10.10 (0.96%)
CORONA Remedies Ltd.
1678.30
1.60 (0.10%)
Strides Pharma Science Ltd.
1094.10
-17.70 (1.59%)
Shilpa Medicare Ltd.
499.25
0.30 (0.06%)
Healthcare Global Enterprises Ltd.
646.15
8.90 (1.40%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 238.68 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 26.69. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 3.69. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 10819.09 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 270.70 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
